Pfizer Acquires Metsera, Viking Therapeutics’ Prospects Attract Attention

Life Science

Opportunities from the Dip? Analyzing Novo Nordisk’s Three Fundamental Pillars

Life Science

Splashing Out 5 Billion! Unveiling Lilly’s Next Growth Engine After the Weight-Loss Injection

Life Science

AI Transforms Health Care: Four Stocks Leading the Revolution

Life Science, Technology

Positive Results from Investigational Drug Trial, Atai Life Sciences Stock Soars Accordingly

Life Science

Pfizer Challenges Novo Nordisk and Eli Lilly with $7.3B Metsera Buyout

Life Science

Regulatory Tailwinds and Analyst Optimism: A Double Dose of Good News for BioNTech’s Stock

Life Science

AbbVie: A Dividend King With Blockbuster Drugs and Patent Power

Life Science

Steady Your Portfolio with These Two “Dividend Kings” Boasting Over 50 Years of Payout Growth

Consumer Goods, Life Science

Miracle or Bubble? These 2 Healthcare Stocks Doubled in Less Than a Month

Life Science

Why Is Overvalued Eli Lilly Using AI to Tell a New Story?

Life Science

Highly Regarded by Multiple Institutions, CRISPR Therapeutics Leads Gene Editing Therapy with a Diverse Pipeline 

Life Science

Novo Nordisk Soars as Oral Wegovy Shows Promise in Weight Loss Trial

Life Science

Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market

Life Science

Roivant Stock Surges on Positive Phase 3 Dermatomyositis Trial

Life Science